Cleavage and polyadenylation specificity factor 6 (CPSF6) is a human protein that binds HIV-1 capsid and mediates nuclear transport and integration targeting of HIV-1 pre-integration complexes. Truncation of the protein at its C-terminal nuclear-targeting arginine/serine-rich (RS-) domain produces a protein, CPSF6-358, that potently inhibits HIV-1 infection by targeting the capsid and inhibiting nuclear entry. To understand the molecular mechanism behind this restriction, the interaction between CPSF6-358 and HIV-1 capsid was characterized using in vitro and in vivo assays. Purified CPSF6-358 protein formed oligomers and bound in vitro assembled wild-type (WT) capsid protein (CA) tubes but not CA tubes containing a mutation in the putative ...
Human immunodeficiency virus type 1 (HIV-1) infection persists for life, requiring the regular admin...
With no current vaccine for Human Immunodeficiency Virus ( it is crucial to study what factors influ...
BACKGROUND: Despite intensive investigation the mechanism by which HIV-1 reaches the host cell nucle...
Human immunodeficiency virus type 1 (HIV-1) capsid binds host proteins during infection, including c...
Human immunodeficiency virus type 1 (HIV-1) capsid binds to multiple host cell proteins after entry ...
The HIV-1 genome enters cells inside a shell comprised of capsid (CA) protein. Variation in CA seque...
<div><p>The host protein CPSF6 possesses a domain that can interact with the HIV-1 capsid (CA) prote...
The HIV-1 genome enters cells inside a shell comprised of capsid (CA) protein. Variation in CA seque...
HIV-1 replication requires transport of nascent viral DNA and associated virion proteins, the retrov...
SummaryHIV-1 replication requires transport of nascent viral DNA and associated virion proteins, the...
<p>(<b>A–B</b>) CPSF6 residue F321 is critical for interaction with HIV-1 CA<sup>N</sup>. (<b>A</b>)...
The HIV-1 capsid performs essential functions during early viral replication and is an interesting t...
<p>(<b>A</b>) Model of CPSF6<sub>313–327</sub> binding to HIV-1 CA hexamer. The hexamer structure wa...
HIV is the causative agent of AIDS, which has no cure. The protein shell that encases the viral geno...
With no current vaccine for Human Immunodeficiency Virus (HIV), it is crucial to study what factors ...
Human immunodeficiency virus type 1 (HIV-1) infection persists for life, requiring the regular admin...
With no current vaccine for Human Immunodeficiency Virus ( it is crucial to study what factors influ...
BACKGROUND: Despite intensive investigation the mechanism by which HIV-1 reaches the host cell nucle...
Human immunodeficiency virus type 1 (HIV-1) capsid binds host proteins during infection, including c...
Human immunodeficiency virus type 1 (HIV-1) capsid binds to multiple host cell proteins after entry ...
The HIV-1 genome enters cells inside a shell comprised of capsid (CA) protein. Variation in CA seque...
<div><p>The host protein CPSF6 possesses a domain that can interact with the HIV-1 capsid (CA) prote...
The HIV-1 genome enters cells inside a shell comprised of capsid (CA) protein. Variation in CA seque...
HIV-1 replication requires transport of nascent viral DNA and associated virion proteins, the retrov...
SummaryHIV-1 replication requires transport of nascent viral DNA and associated virion proteins, the...
<p>(<b>A–B</b>) CPSF6 residue F321 is critical for interaction with HIV-1 CA<sup>N</sup>. (<b>A</b>)...
The HIV-1 capsid performs essential functions during early viral replication and is an interesting t...
<p>(<b>A</b>) Model of CPSF6<sub>313–327</sub> binding to HIV-1 CA hexamer. The hexamer structure wa...
HIV is the causative agent of AIDS, which has no cure. The protein shell that encases the viral geno...
With no current vaccine for Human Immunodeficiency Virus (HIV), it is crucial to study what factors ...
Human immunodeficiency virus type 1 (HIV-1) infection persists for life, requiring the regular admin...
With no current vaccine for Human Immunodeficiency Virus ( it is crucial to study what factors influ...
BACKGROUND: Despite intensive investigation the mechanism by which HIV-1 reaches the host cell nucle...